An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world’s third leading cause of cancer-related deaths. By analyzing patient-specific genetic data, scientists identified a protein system that could predict chemotherapy resistance and open the door to more tailored, effective treatments.
This article was originally published on MedicalXpress.com

